Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

David Liu; Bastian Schilling; Derek Liu; Antje Sucker; Elisabeth Livingstone; Livnat Jerby-Arnon; Lisa Zimmer; Ralf Gutzmer; Imke Satzger; Carmen Loquai; Stephan Grabbe; Natalie Vokes; Claire A Margolis; Jake Conway; Meng Xiao He; Haitham Elmarakeby; Felix Dietlein; Diana Miao; Adam Tracy; Helen Gogas; Simone M Goldinger; Jochen Utikal; Christian U Blank; Ricarda Rauschenberg; Dagmar von Bubnoff; Angela Krackhardt; Benjamin Weide; Sebastian Haferkamp; Felix Kiecker; Ben Izar; Levi Garraway; Aviv Regev; Keith Flaherty; Annette Paschen; Eliezer M Van Allen; Dirk Schadendorf

doi:10.1038/s41591-020-0975-4

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Nat Med. 2020 Jul;26(7):1147. doi: 10.1038/s41591-020-0975-4.

Authors

David Liu^#^{1

2}, Bastian Schilling^#^{3

4

5}, Derek Liu^{1

2

6}, Antje Sucker^{4

5}, Elisabeth Livingstone^{4

5}, Livnat Jerby-Arnon², Lisa Zimmer^{4

5}, Ralf Gutzmer⁷, Imke Satzger⁷, Carmen Loquai⁸, Stephan Grabbe⁸, Natalie Vokes^{1

2}, Claire A Margolis^{1

2}, Jake Conway^{2

6}, Meng Xiao He^{2

6

9}, Haitham Elmarakeby^{1

2}, Felix Dietlein^{1

2}, Diana Miao^{1

2

6}, Adam Tracy², Helen Gogas¹⁰, Simone M Goldinger¹¹, Jochen Utikal^{12

13}, Christian U Blank¹⁴, Ricarda Rauschenberg^{15

16

17}, Dagmar von Bubnoff¹⁸, Angela Krackhardt^{5

19}, Benjamin Weide²⁰, Sebastian Haferkamp²¹, Felix Kiecker²², Ben Izar^{1

2}, Levi Garraway²³, Aviv Regev², Keith Flaherty²⁴, Annette Paschen^{4

5}, Eliezer M Van Allen^{25

26}, Dirk Schadendorf^{27

28}

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA, USA.
² Broad Institute of Harvard and MIT, Cambridge, MA, USA.
³ Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
⁴ Department of Dermatology, University Hospital, Essen, Germany.
⁵ German Cancer Consortium of Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany.
⁶ Harvard Medical School, Boston, MA, USA.
⁷ Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
⁸ Department of Dermatology, University Medical Center, Mainz, Germany.
⁹ Biophysics Program, Harvard University, Cambridge, MA, USA.
¹⁰ First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
¹¹ Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
¹² Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
¹³ Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.
¹⁴ Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
¹⁵ Skin Cancer Center at the University Cancer Centre, Department of Dermatology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
¹⁶ National Center for Tumor Diseases, Dresden, Germany.
¹⁷ German Cancer Research Centre, Heidelberg, Germany.
¹⁸ Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
¹⁹ Medizinische Klinik III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
²⁰ Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany.
²¹ Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
²² Department of Dermatology, University Hospital Berlin, Berlin, Germany.
²³ Eli Lilly and Co., Indianapolis, IN, USA.
²⁴ Massachusetts General Hospital, Boston, MA, USA.
²⁵ Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
²⁶ Broad Institute of Harvard and MIT, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
²⁷ Department of Dermatology, University Hospital, Essen, Germany. dirk.schadendorf@uk-essen.de.
²⁸ German Cancer Consortium of Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany. dirk.schadendorf@uk-essen.de.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum